The use of zenocutuzumab for NRG1 fusion–positive tumors [Interview] Miscellaneous
| Author: | Schram, A. |
| Title: | The use of zenocutuzumab for NRG1 fusion–positive tumors [Interview] |
| Keywords: | protein kinase b; cancer chemotherapy; note; pancreas cancer; neoplasm; cancer immunotherapy; quality of life; breast cancer; epidermal growth factor receptor 2; lung cancer; phosphatidylinositol 3 kinase; histology; protein tyrosine kinase inhibitor; cardiotoxicity; gene fusion; bile duct carcinoma; corticosteroid; epidermal growth factor receptor 3; bioinformatics; tumor gene; antihistaminic agent; non small cell lung cancer; neu differentiation factor; first-line treatment; afatinib; human; circulating tumor dna; liquid biopsy; zenocutuzumab |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 22 |
| Issue: | 10 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2024-12-01 |
| Start Page: | 487 |
| End Page: | 489 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Source: Scopus |
MSK Authors
-
122Schram